Many patients with generalized anxiety disorder (GAD) do not receive adequate treatment.
Several classes of drugs, including benzodiazepines, azapirones, selective serotonin …

Less than one third of people afflicted with generalized anxiety disorder (GAD) experience
spontaneous remission, and the symptoms of GAD wax and wane throughout a person's life …

Generalized anxiety disorder (GAD) is common in community and clinical settings. The
associated individual and societal burden is substantial, but many of those who could …

Objective: Generalized anxiety disorder (GAD) is common, chronic, and debilitating.
Treatment with benzodiazepines and newer antidepressants is often inadequate. This article …

A meta-analytic review of the efficacy of pharmacological treatment in generalized anxiety
disorder was conducted. The main substance classes were compared: benzodiazepines …

Accumulating evidence suggests that a large proportion of patients diagnosed with
generalized anxiety disorder suffer from a chronic or recurrent condition that is associated …

Abstract Generalized Anxiety Disorder (GAD) is a common and often disabling disorder. This
paper reviews the pharmacological treatment of GAD, based on the findings of published …

Evidence suggests that generalized anxiety disorder (GAD) has a fairly chronic course
marked by significant long-term distress and comorbidity. Research has focused on short …

More than half of patients with generalized anxiety disorder (GAD) have chronic and
persistent symptomatology that may warrant ongoing pharmacotherapy. Many of these …

Selection of appropriate treatment for generalized anxiety disorder (GAD) is influenced by
several considerations, including psychiatric comorbidity. Emerging data suggest that GAD …